세계의 심실보조장치 시장(2023-2030년)

Global Ventricular Assist Devices Market - 2023-2030

US $ 4,350 ￦ 5,968,000

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850 ￦ 6,654,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850 ￦ 10,770,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

개요

심실보조장치(VAD)은 심장이 약하거나 기능이 저하된 사람의 심장 기능과 혈류를 지원하는 데 사용되는 기계식 펌프입니다. 심실보조장치은 기능 장애가있는 심장의 기능을 부분적으로 또는 완전히 대체하는 데 사용됩니다.

심실보조장치(VAD)은 우심실(RVAD) 또는 좌심실(LVAD) 또는 양심실(BiVAD)을 보조하도록 설계되어 있습니다. 심실보조장치(VAD)은 심장의 업무량을 줄임으로써 수명을 연장하고 피로, 호흡곤란과 같은 증상을 개선할 수 있습니다.

시장 역학: 시장 성장 촉진요인과 시장 성장 억제요인

심장질환과 심부전 부담 증가

심장 질환 증가와 심부전 부담 증가는 시장 성장의 원동력이 될 것으로 예상됩니다. 이러한 요인은 심실보조장치에 대한 수요를 증가시킬 것입니다. 또한, 기술 발전 증가와 장치 승인 증가도 시장을 견인할 것으로 예상됩니다.

예를 들어, 2022년 발표된 보고서에 따르면, 심부전 유병률은 세계적으로 2,600만 명으로 추정되며, 이는 세계 의료 비용 증가에 기여하고 있습니다. 심부전은 높은 이환율과 사망률을 동반하는 질병으로 세계적으로 여전히 높은 빈도로 확산되고 있습니다.

또한, Journal of the American College of Cardiology에 게재된 보고서에 따르면, 높은 수축기 혈압은 2021년에 약 1,080만 명의 심혈관 질환으로 인한 사망, 전체적으로는 약 1,130만 명의 조기 심혈관 질환으로 인한 사망을 초래할 수 있는 세계 주요 수정 가능한 위험 요인으로 남아 있으며, 특히 허혈성 심장질환과 뇌졸중 관련 사망과의 연관성이 지적되고 있습니다. 따라서 위의 요인들이 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다.

억제요인

장비 및 시술의 고비용

높은 비용과 혈전, 출혈 등 심실보조장치(VAD) 사용에 따른 심각한 합병증 등의 요인이 세계 심실보조장치(VAD) 시장의 성장을 억제하고 있습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter의 Five Forces 분석
• 공급망 분석
• 가격 분석
• 규제 분석
• 러시아·우크라이나 전쟁의 영향 분석
• DMI의 견해

제6장 COVID-19 분석

제7장 제품 유형별

• 좌실보조 순환 장비
• 우실보조 순환 장비
• 양심실 어시스트 디바이스

제8장 디자인별

• 삽입형 심실보조장치
• 경피적 심실보조장치

제9장 용도별

• Bridge to Candidacy Therapy
• Bridge to Transplant Therapy
• Bridge to Recovery Therapy
• Destination Therapy

제10장 최종사용자별

• 병원
• 외래수술센터(ASC)
• 전문 클리닉
• 기타

제11장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 기타 아시아태평양
• 중동 및 아프리카

제12장 경쟁 구도

• 경쟁 시나리오
• 시장 현황/점유율 분석
• M&A분석

제13장 기업 개요

• Abbott Laboratories
  • 기업 개요
  • 제품 포트폴리오와 설명
  • 재무 개요
  • 주요 발전
• Abiomed Inc
• Berlin Heart GmbH
• Medtronic Plc
• Jarvik Heart, Inc
• EVAHEART, INC.
• Cirtec
• CorWave SA
• Calon Cardio-Technology Ltd
• Teleflex Incorporated.

제14장 부록

LSH

영문 목차

영문목차

Overview

A ventricular assist device (VAD) is a mechanical pump that is used to support heart function and blood flow in people with weak or failing hearts. It is used either to partially or to completely replace the function of a failing heart.

VADs are designed to assist either the right ventricle (RVAD) or the left ventricle (LVAD) or to assist both ventricles (BiVAD). By relieving the heart's workload, a VAD can prolong life and improve symptoms such as fatigue and breathlessness.

Market Dynamics: Drivers & Restraints

Increasing cardiac disease and heart failure burden

The increase in the number of cardiac diseases and the increase in the heart failure burden is expected to drive the market growth. These factors increase the demand for ventricular assist devices. Additionally, the increase in technological advancements and the increase in the approvals of the devices are also expected to drive the market.

For instance, according to the report published in 2022, it is estimated that heart failure has an estimated prevalence of 26 million people worldwide and contributes to increased healthcare costs worldwide. Heart failure remains a highly prevalent disorder worldwide with a high morbidity and mortality rate.

Additionally, according to the report published in the Journal of the American College of Cardiology, high systolic blood pressure remains the leading modifiable risk factor globally for attributable premature cardiovascular deaths, which was about 10.8 million cardiovascular deaths and 11.3 million deaths overall in 2021, and has been particularly linked to ischemic heart disease and stroke-related deaths. Thus, the above factors are expected to drive the market growth in the forecast period.

Restraint

High costs of devices and the procedures

Factors such as high cost and serious complications involved with the usage of ventricular assist devices such as blood clots and bleeding, are restricting the global ventricular assist devices market growth.

Segment Analysis

The global ventricular assist devices market is segmented based on product type, design application, end-user and region.

Left ventricular assist device segment accounted for 48.3% of the market share

The left ventricular assist devices segment is expected to hold a dominant share in the global ventricular assist devices market because of the advantages of the LAVD over other types. The left ventricular assist device (LVAD) is the most common device applied to a defective heart (it is sufficient in most cases.

Left Ventricular Assist Devices (LVADs) are mechanical devices that are implanted in patients with advanced heart failure, help the heart pump blood more effectively, and could benefit patients with advanced heart failure as they await donors. They improve the function of the kidneys, liver, brain, and other organs by increasing blood flow to the body.

Left Ventricular Assist Device (LVAD) helps the left side of the heart pump blood to a large blood vessel called the aorta and to the rest of the body.

Additionally, the increase in the number of heart diseases, an increase in the geriatric population, and the increase in the number of launches of the devices are expected to drive the segment's growth. Thus, the above factors are expected to hold a significant position in the market share.

Geographical Analysis

North America is expected to hold a significant position in the global ventricular assist devices market share

North America holds a dominant share in the ventricular assist devices market share owing to technological advancements and, an increase in the burden of heart diseases and is expected to continue throughout the forecast period.

For instance, according to the report by CDC in 2021, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease and about 695,000 people in the United States died from heart disease in 2021.

According to the report by the Centers for Disease Control & Prevention (CDC) in 2023, it is estimated that about 805,000 people in the United States have a heart attack every year. Among these, 605,000 are a first heart attack and 200,000 happen to people who have already had a heart attack.

Thus, an increase in the burden of heart diseases, and also increase in the advancements in the region, and the presence of major companies in the region are expected to drive market growth in the region.

COVID-19 Impact Analysis:

The COVID-19 has impacted the ventricular assist devices market negatively. The reduction in the number of cardiovascular surgeries and the closure of hospitals during the period of lockdown has impacted the market growth. People refused to visit hospitals for treatment procedures because of the spread of the virus. Thus, COVID-19 has reduced the growth of the market.

Competitive Landscape

The leading companies with a significant market share include: Abbott Laboratories, Abiomed Inc, Berlin Heart GmbH, Medtronic Plc, Jarvik Heart, Inc., EVAHEART, INC., Cirtec, CorWave SA, Calon Cardio-Technology Ltd, and Teleflex Incorporated.

Key Developments

• On June 20, 2023, CorWave declared that its Series C round has brought in a total of $64 million to fund entry into clinical trials and initial manufacturing of its wave membrane LVAD.
• On January 6, 2022, the IIT Kanpur has forayed into the field of medical technology with its ambition of creating the world's most advanced Left Ventricular Assist Device (LVAD).

Why Purchase the Report?

• To visualize the global ventricular assist devices market segmentation based on product type, design, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of ventricular assist devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global ventricular assist devices market report would provide approximately 69 tables, 68 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Design
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing cardiac disease and heart failure burden
    • 4.1.1.2.
  • 4.1.2. Restraints
    • 4.1.2.1. High costs of devices and the procedures
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Left Ventricular Assist Device *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Right Ventricular Assist Device
• 7.4. Biventricular Assist Device

8. By Design

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 8.1.2. Market Attractiveness Index, By Design
• 8.2. Implantable Ventricular Assist Devices *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Transcutaneous Ventricular Assist Devices

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Bridge to Candidacy Therapy *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Bridge to Transplant Therapy
• 9.4. Bridge to Recovery Therapy
• 9.5. Destination Therapy

10. By End-User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.1.2. Market Attractiveness Index, By End-User
• 10.2. Hospitals *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Ambulatory Surgical Centers
• 10.4. Specialty Clinics
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Design
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Abbott Laboratories *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Abiomed Inc
• 13.3. Berlin Heart GmbH
• 13.4. Medtronic Plc
• 13.5. Jarvik Heart, Inc
• 13.6. EVAHEART, INC.
• 13.7. Cirtec
• 13.8. CorWave SA
• 13.9. Calon Cardio-Technology Ltd
• 13.10. Teleflex Incorporated.

LIST NOT EXHAUSTIVE.

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us

관련자료